FIVE PRIME THERAPEUTICS, INC. Cashflow Statement

Ask AI

Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2020 12 months to Dec 31, 2020	FY2019 12 months to Dec 31, 2019	FY2018 12 months to Dec 31, 2018	FY2017 12 months to Dec 31, 2017	FY2016 12 months to Dec 31, 2016
Net income (loss)
Operating activities
Net loss
Adjustments to reconcile net loss to net cash from operating activities:
Depreciation and amortization
Impairment of fixed assets
Amortization of right-of-use assets
Impairment of right-of-use assets
Write-off of right-of-use assets
Stock-based compensation expense
Amortization of discounts and premiums on marketable securities
Excess tax benefits from employee equity incentive plans
Deferred income taxes
Non-cash operating lease expense
(Gain) loss on disposal of property and equipment

Changes in operating assets and liabilities:
Receivables from collaborative partners
Income tax receivable
Prepaid, other current assets, and other long-term assets
Restricted cash
Accounts payable
Accrued personnel-related expenses
Deferred revenue
Deferred rent
Income tax payable
Other accrued liabilities, and other long-term liabilities

Net cash provided by (used in) operating activities
Operating lease liabilities
Net cash used in operating activities
Investing activities
Purchases of marketable securities
Maturities of marketable securities
Proceeds from sales of property and equipment
Purchases of property and equipment
Net cash (used in) provided by investing activities
Financing activities
Proceeds from follow-on public offering of common stock, net of issuance costs
At-The-Market
Total proceeds from follow-on public offering of common stock, net of issuance costs
Proceeds from issuance of common stock under equity incentive plans
Repurchase of shares to satisfy tax withholding obligations
Excess tax benefits from employee equity incentive plans
Net increase (decrease) in cash and cash equivalents
Proceeds from disgorgement of stockholder's short-swing profits
Net cash provided by (used in) financing activities

Net increase (decrease) in cash and cash equivalents and restricted cash
Cash, cash equivalents and restricted cash at beginning of period
Cash and cash equivalents at end of period
Restricted cash at end of period
Cash, cash equivalents and restricted cash at end of period
Income taxes paid
Supplemental information
Property and equipment purchases included in accrued liabilities
Tenant improvement by the landlord
Lease liability arising from obtaining right-of-use asset
Public offering issuance costs included in accrued liabilities
Cash and cash equivalents at beginning of period
Restricted cash at beginning of period

Comments